Intelligent Bio Solutions Inc
INBS
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.66M
Close$
$-15.56
732.6% downside
Current Fair Value
732.6% downsideOvervalued by 732.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.66 Million |
|---|---|
| Enterprise Value | $-3,354,200.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-20 |
| Beta | 4.24 |
| Outstanding Shares | 1,594,496 |
Return
| Return on Equity | -129.59% |
|---|---|
| Return on Assets | -78.13% |
| Return on Invested Capital | -115.25% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -2.81 |
| Price to Sales | 1.23 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | -0.86 |
| Enterprise Value to EBIT | 0.28 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.55 |
| Debt to Equity | 0.21 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$1.40
Average shareholder expectationRevenue Estimate
$7.20 M
Average shareholder expectationNext Earnings Call
Expected Date
August 14, 2026
EPS Estimate
$3.30
Average shareholder expectationRevenue Estimate
$8.80 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 25.66%▲ 13.40% |
|---|---|
| Total Invested | $1.38M▲ 13.43% |
| Investors Holding | 12▲ 3.00% |
ESG Score
No data
About Intelligent Bio Solutions Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...